|
|
Your guide to
MOUNJARO® (tirzepatide) and the KwikPen® device |
Your healthcare professional may prescribe Mounjaro together with a reduced-calorie diet and increased physical activity for weight loss and to help keep your weight under control if you are an adult, who has:
Do not use Mounjaro:
aBMI is a measure of your weight in relation to your height. This website is produced by Eli Lilly and Company, the manufacturer of this medicine. This information does not replace the Patient Information Leaflet (PIL) or the Instructions for Use (IFU) that come with your medicine. Please read the PIL and IFU carefully.
Watch a video on how to use the
MOUNJARO KWIKPEN
This medicine is subject to additional monitoring.
|
What is Mounjaro? Mounjaro is a once weekly injection for weight loss and weight maintenance in adults. It contains an active substance called tirzepatide (tir-zep-a-tide).
Mounjaro activates the actions of 2 natural substances in your body, called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Mounjaro primarily works by regulating your appetite, giving you a sense of satiety (fullness), making you feel less hungry and experience less food cravings. It is important to continue to follow the advice on diet and exercise given to you by your healthcare professional. Please note devices shown in this guide are for illustrative purposes only and are not actual size |
How Mounjaro works A few of the ways Mounjaro helps you lose weight include: Reducing how much food you crave and eat Slowing down how quickly food leaves your stomach. This lessens over time Regulating fat utlisation Always use Mounjaro exactly as your Doctor or pharmacist has told you. Check with your Doctor or pharmacist if you are not sure how to use this medication. |
Introducing the Mounjaro KwikPen Mounjaro KwikPen is a disposable multi-dose single-patient-use pre-filled pen.
Parts of the Mounjaro KwikPen |
How much
Mounjaro to use
The starting dose is 2.5 mg once a week for four weeks. After four weeks your healthcare professional will increase your dose to 5 mg once a week.
Each person responds differently to Mounjaro. Your healthcare professional may increase your dose by 2.5 mg increments to 7.5 mg, 10 mg, 12.5 mg or 15 mg once a week if you need it. In each case, your healthcare professional will tell you to stay on a particular dose for at least four weeks before going to a higher dose. Do not change your dose unless your healthcare professional has told you to. |
Choosing
when to use Mounjaro
|
Preparing to inject Mounjaro KwikPen
Supplies needed to give your injection
|
Step - 1
Step - 2
Step - 3
Step - 4
Step - 5
Step - 6
Step - 7
Step - 8
Step - 9
|
Step - 1
Step - 2
Step - 3
Step - 4
Step - 5
Step - 6
Step - 7
Step - 8
Step - 9
|
Choosing
your injection site
Step - 10
Change (rotate) your injection site each week. You may use the same area of your body, but be sure to choose a different injection site in that area. If you also inject insulin, choose a different injection site for that injection. |
Choosing
your injection site
Step - 10
Change (rotate) your injection site each week. You may use the same area of your body, but be sure to choose a different injection site in that area. If you also inject insulin, choose a different injection site for that injection. |
Injecting
your Mounjaro KwikPen
Step - 11
Step - 12
Step - 13
|
Injecting
your Mounjaro KwikPen
Step - 11
Step - 12
Step - 13
|
After
your Mounjaro KwikPen injection
Step - 14
Step - 15
Step - 16
Step - 17
Troubleshooting
|
After
your Mounjaro KwikPen injection
Step - 14
Step - 15
Step - 16
Step - 17
|
Storage and disposal of your Mounjaro KwikPen & needles Unused pens
Store unused pens in the refrigerator between 2°C to 8°C
Unused pens may be used until the expiration date printed on the label if the pen has been kept in the refrigerator
Do not freeze. If the pen has been frozen, DO NOT USE
Keep this medicine out of the sight and reach of children.
Used pens
You may store your used pen at room temperature up to 30°C after your injection. Keep away from heat. Keep your pen and needles out of the sight and reach of children. Dispose of the pen 30 days after first use. Dispose of the pen after receiving 4 weekly doses. Disposing of Mounjaro KwikPen and needles
|
Missed a dose of Mounjaro?
If it’s been 4 days or less since you should have used Mounjaro:
If it’s been more than 4 days since you should have used Mounjaro:
Do not use a double dose to make up for a forgotten dose. For example, if your regular dose day is Sunday:
Do not use a double dose to make up for a forgotten dose. If you use more Mounjaro than you should talk to your doctor immediately. Too much of this medicine may cause low blood sugar (hypoglycaemia) and can make you feel sick or be sick. Do not stop using Mounjaro without talking with your prescribing healthcare professional. If you stop using Mounjaro, and you have type 2 diabetes, your blood sugar levels can increase. If you have any further questions on the use of this medicine, ask your prescribing healthcare professional. |
Possible
side effects
Like all medicines, Mounjaro can cause side effects, although not everybody gets them. Please read the PIL for a full list of side effects; some of these are listed below. Serious side effects
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
Very common (may affect more than 1 in 10 people)
**Constipation and vomiting are very common when used for weight management, but common when used for type 2 diabetes. Uncommon (may affect up to 1 in 100 people)
Common (may affect up to 1 in 10 people)
**Increased levels of amylase is uncommon in weight management.
When starting treatment with Mounjaro, in some cases you may experience loss of fluids/dehydration, e.g. due to vomiting, nausea and/or diarrhoea, which may lead to a decrease in kidney function. It is important to avoid dehydration by drinking plenty of fluids. Contact your doctor if you have any questions or concerns.
|
Additional
warnings and precautions
Talk to your healthcare professional before using Mounjaro if:
Other medicines and Mounjaro
Pregnancy
Breast-feeding
Driving and using machines
Children and adolescents
Mounjaro contains sodium
Mounjaro KwikPen contains benzyl alcohol
|
Where
to learn more:
|
Resources
Your guide to
MOUNJARO
®
(tirzepatide) and the KwikPen device
Instructions for Use
Patient Information Leaflet
Mounjaro 2.5 mg KwikPen – Shelf Life Extension
We wish to inform you that specific batches of Mounjaro 2.5 mg KwikPen have been granted an extension of shelf life from 9 months to 14 months. The letter linked below provides more information if you have been prescribed product from an affected batch. Download
REPORTING SIDE EFFECTS
SIDE EFFECTS AND PRODUCT COMPLAINTS SHOULD BE REPORTED
If you experience side effects talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. To report a side effect or product complaint with a Lilly product please call Lilly on
+44 (0) 1256 315000
. Additionally reporting forms and further information can be found at
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
|
© 2024 Eli Lilly and Company. All rights reserved.
Mounjaro ®, KwikPen ® and Lilly are registered trademarks of Eli Lilly and Company. This website is published by Eli Lilly and Company, the manufacturer of this medicine, and is intended for people prescribed Mounjaro in Great Britain. |
Reporting Side Effects |
You are now leaving obesity.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to obesity.mounjaro.co.uk" to close this window and return to obesity.mounjaro.co.uk
Return to obesity.mounjaro.co.uk
Continue
|
You are now leaving obesity.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to obesity.mounjaro.co.uk" to close this window and return to obesity.mounjaro.co.uk
Return to obesity.mounjaro.co.uk
Continue
|
You are now leaving obesity.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to obesity.mounjaro.co.uk" to close this window and return to obesity.mounjaro.co.uk
Return to obesity.mounjaro.co.uk
Continue
|
You are now leaving obesity.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to obesity.mounjaro.co.uk" to close this window and return to obesity.mounjaro.co.uk
Return to obesity.mounjaro.co.uk
Continue
|
ou are now leaving obesity.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to obesity.mounjaro.co.uk" to close this window and return to obesity.mounjaro.co.uk
Return to diabetes.mounjaro.co.uk
Continue
|
You are now leaving diabetes.mounjaro.co.uk The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click "Continue" to leave site or "Return to diabetes.mounjaro.co.uk" to close this window and return to diabetes.mounjaro.co.uk
Return to diabetes.mounjaro.co.uk
Continue
|